Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Nurix Therapeutics (NRIX) Q3 2025 Earnings
NRIX
9
Jul
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.76
-0.68
-0.6
-0.52
Details
Expected EPS
-0.718688
Actual EPS
-0.52
Surprise EPS
0.2
Surprise Percent
+27.65%
Description
Nurix Therapeutics (NRIX) has reported earnings of -0.52 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login